BioPharma Resources

Drug Trial Radar · NCT07767903

A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety Disorder

A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicenter Trial to Compare the Efficacy and Safety of a Fixed Dose of SEP-363856 to Placebo in the Treatment of Adults With Generalized Anxiety Disorder

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 384 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

384

Planned (sponsor's estimate)

Start

Aug 6, 2026

Primary completion

Oct 25, 2028

Study completion Nov 1, 2028

Sponsor

Sponsor type
Industry
First posted
Aug 17, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a global, phase 3, randomized, double-blind, parallel-group, 2-arm, placebo controlled, multicenter trial designed to compare the efficacy, safety and tolerability of a fixed dose of SEP-363856 (75 millligrams per day \[mg/day\]) to placebo over an 8-week double-blind treatment period in adults with generalized anxiety disorder (GAD).

Conditions

  • Generalized Anxiety Disorder

Interventions

  • SEP-363856Drug

    Oral tablet

  • PlaceboDrug

    Oral tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline at Week 8 in Hamilton Anxiety Rating Scale (HAM-A) Total ScoreTime frame: Baseline, Week 8

Locations

21 sites in 1 country. Site status is shown where the registry gives one.

  • IMA Clinical Research - Phoenix

    Phoenix, Arizona · Recruiting

  • Calneuro Research Group

    Los Angeles, California · Recruiting

  • Anderson Clinical Research

    Redlands, California · Recruiting

  • Schuster Medical Research Institute SMRI

    Sherman Oaks, California · Recruiting

  • Concierge Clinical Trials

    Valley Village, California · Recruiting

  • Velocity Clinical Research - Hallandale Beach

    Hallandale, Florida · Recruiting

  • Clinical Neuroscience Solutions Inc. (CNS) - Orlando

    Orlando, Florida · Recruiting

  • ActivMed Practices & Research, LLC

    Methuen, Massachusetts · Recruiting

  • Adams Clinical - Watertown

    Watertown, Massachusetts · Recruiting

  • Lumina Clinical Research Center

    Cherry Hill, New Jersey · Recruiting

  • Basil Clinical

    Jamaica, New York · Recruiting

  • IMA Clinical Research NYC Uptown

    New York, New York · Recruiting

  • Adams Clinical - Bronx

    The Bronx, New York · Recruiting

  • Paradigm Research Professionals LLC

    Oklahoma City, Oklahoma · Recruiting

  • Summit Research Network

    Portland, Oregon · Recruiting

  • Adams Clinical Philadelphia

    Philadelphia, Pennsylvania · Recruiting

  • CNS Healthcare - Memphis

    Memphis, Tennessee · Recruiting

  • Donald J. Garcia, Jr, MD, PA

    Austin, Texas · Recruiting

  • DM Clinical Research - Bellaire

    Houston, Texas · Recruiting

  • Vitra Behavioral and Metabolic Research Center

    Fairfax, Virginia · Recruiting

  • Core Clinical Research

    Everett, Washington · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.